The therapeutic expertise to help you address unmet clinical needs
At D2V Clinical, we are committed to helping biopharmaceutical sponsors with limited resources expedite drug signal detection and program advancement in areas of unmet need. As global experts in oncology, hematology and rare disease, we tap into the collective power of our vast knowledge and insight to help you get better medicines to patients faster.
We know what you’re facing because we’ve been in your shoes
Our leaders are all industry experts, each with more than 20 years of experience advancing clinical research – including roles in pharma, biotech, academia, and at the FDA. We have been accountable and responsible for every step of clinical development in the US, China, and beyond.
80+
Phase I & II experiences
8,200+
patients
1,800+
sites
50+
Phase I & II experiences
4,100+
patients
800+
sites
10+
Phase I & II experiences
1,600+
patients
400+
sites
Expertise in a wide range of modalities and trial designs
Modalities
- Antibody drug conjugates
- Cell and gene therapy
- Companion diagnostics
- Immuno-oncology
- Monoclonal antibodies
- Oncolytic viruses
- Small molecules
Trial Types
- Adaptive trial design
- Basket trials
- Combination trials
Trust the team that has fixed the mistakes and achieved the successes. Our experts have held senior roles at these leading organizations.
The connections to help reach the finish line
We have a strong network of sites and strategic partnerships with leading medical centers in the US and China. D2V Clinical can advise on a global approach for your development plan that will provide both an abundant and diverse trial population with lower operational costs.